Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Oculoplastics > Discrepancies found in IOP measurement methods among patients with thyroid-associated orbitopathy
  • Oculoplastics

Discrepancies found in IOP measurement methods among patients with thyroid-associated orbitopathy

Ophthalmology 360

In patients with thyroid-associated orbitopathy (TAO), the non-contact airpuff tonometer (NCT) significantly overestimates intraocular pressure (IOP) values compared to the Goldmann applanation tonometer (GAT) and the iCARE rebound tonometer, according to a study. On the other hand, the iCARE rebound tonometer provides IOP measurements that are comparable to the gold standard GAT in these patients. This suggests that careful consideration should be given to the choice of tonometry method when measuring IOP in TAO patients, as the accuracy of measurements can vary among different tonometers.

A total of 98 eyes from 49 adult patients with TAO were examined. All patients had a history of mild to moderate TAO, evidence of thyroid disease, and no clinical signs or symptoms of active disease. Importantly, none of the patients exhibited diplopia in direct gaze direction.

The measurements were conducted using NCT, iCARE, and GAT, with the results revealing notable differences. The mean IOP was recorded as 18.1 ± 2.4 mmHg with GAT, 22.3 ± 5.0 mmHg with NCT, and 18.0 ± 2.4 mmHg with iCARE.

Bland-Altman analysis indicated a negligible mean difference of -0.1 ± 1.16 mmHg between GAT and iCARE measurements, suggesting comparable results. However, the mean difference between GAT and NCT measurements was 4.2 ± 3.6 mmHg, signifying a significant overestimation by NCT. Similarly, the mean difference between iCARE and NCT measurements was -4.3 ± 3.7 mmHg, again indicating a significant discrepancy.

Statistical analysis confirmed no significant difference between GAT and iCARE, while there was a substantial difference between GAT and NCT and iCARE and NCT.

Reference
Karhanová M, Kalitová J, Malušková M, et al. Comparison of Three Methods of Tonometry in Patients with Inactive Thyroid-Associated Orbitopathy. Cesk Slov Oftalmol. 2023 Fall;79(6):318-323. English. doi: 10.31348/2023/38. PMID: 38086704.

Share

Related Content

  • Oculoplastics

Pain measures may help track treatment response in Graves’ orbitopathy

FDA approves Eysuvis for short-term treatment of dry eye disease
  • Oculoplastics

FDA approves Lumvoa for active and chronic thyroid eye disease

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Oculoplastics

Blepharoplasty candidates prioritize function over aesthetics, survey finds

  • Oculoplastics

Integrating amniotic allografts into modern oculoplastic reconstruction: a practical perspective

  • The Ophthalmic Project

The next generation of amniotic membranes for the treatment of corneal epithelial defects

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon